4.7 Article

Learning Curve From 450 Cases of Robot-Assisted Pancreaticoduocectomy in a High-Volume Pancreatic Center Optimization of Operative Procedure and a Retrospective Study

期刊

ANNALS OF SURGERY
卷 274, 期 6, 页码 E1277-E1283

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLA.0000000000003664

关键词

learning curve; pancreatic fistula; pancreatic tumor; robot-assisted pancreaticoduodenectomy

类别

向作者/读者索取更多资源

This study retrospectively analyzed 450 cases of robot-assisted pancreaticoduodenectomy to describe the experience and learning curve, with improvements in operative time and estimated blood loss observed over time. The inflexion points in the RPD learning curve were identified around cases 100 and 250, and a significantly lower incidence of pancreatic leak was found in the last 350 cases compared to the first 100 cases.
Objective: We aimed to describe our experience and the learning curve of 450 cases of robot-assisted pancreaticoduodenectomy (RPD) and optimize the surgical process so that our findings can be useful for surgeons starting to perform RPD. Summary Background Data: Robotic surgical systems were first introduced 20 years ago. Pancreaticoduodenectomy (PD) is a challenging surgery because of its technical difficulty. RPD may overcome some of these difficulties. Methods: The medical records of 450 patients who underwent RPD between May 2010 and December 2018 at the Shanghai Ruijin Hospital were retrospectively analyzed. Operative times and estimated blood loss (EBL) were analyzed and the learning curve was determined. A cumulative sum (CUSUM) analysis was used to identify the inflexion points. Other postoperative outcomes, postoperative complications, and long-term follow-up were also analyzed. Results: Operative time improved gradually over time from 405.4 +/- 112.9 minutes (case 1-50) to 273.6 +/- 70 minutes (case 301-350) (P < 0.001). EBL improved from 410 +/- 563.5 mL (case 1-50) to 149.0 +/- 103.3 mL (case 351-400) (P < 0.001). According to the CUSUM curve, there were 3 phases in the RPD learning curve. The inflexion points were around cases 100 and 250. The incidence of pancreatic leak in the last 350 cases was significantly lower than that in the first 100 cases (30.0% vs 15.1%, P = 0.003). Conclusions: RPD is safe and feasible for selected patients. Operative and oncologic outcomes were much improved after experience of 250 cases. Our optimization of the surgical process may have also contributed to this. Future prospective and randomized studies are needed to confirm our results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study

Yuanchi Weng, Jiabin Jin, Zhen Huo, Yusheng Shi, Yu Jiang, Xiaxing Deng, Chenghong Peng, Baiyong Shen

Summary: Robotic-assisted distal pancreatectomy has advantages in operative time, blood loss, spleen preservation, infection rate, and gastrointestinal function recovery over open distal pancreatectomy for treating benign and low-grade malignant pancreatic tumors.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2021)

Article Surgery

Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis

Yuanchi Weng, Yu Jiang, Ningzhen Fu, Jiabin Jin, Yusheng Shi, Zhen Huo, Xiaxing Deng, Chenghong Peng, Baiyong Shen

Summary: Robot-assisted minimally invasive surgery for PDAC showed comparable disease-free survival and overall survival outcomes to open surgery in a propensity score-matched analysis. Further confirmation through prospective randomized controlled trials is needed.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2021)

Article Surgery

Comparison between robot-assisted middle pancreatectomy and robot-assisted distal pancreatectomy for benign or low-grade malignant tumours located in the neck of the pancreas: A propensity score matched study

Yusheng Shi, Qingrou Wang, Zhihao Shi, Junjie Xie, Jiabin Jin, Hao Chen, Xiaxing Deng, Chenghong Peng, Baiyong Shen

Summary: This study compared the short-term and long-term outcomes between robot-assisted middle pancreatectomy (RMP) and robot-assisted distal pancreatectomy (RDP), with RDP showing advantages in short-term outcomes, especially in reducing the rate of clinical-relevant postoperative pancreatic fistula (CR-POPF).

INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY (2021)

Article Oncology

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer

Yusheng Shi, Xinjing Wang, Weize Wu, Junjie Xie, Jiabin Jin, Chenghong Peng, Xiaxing Deng, Hao Chen, Baiyong Shen

Summary: This study evaluated prognostic factors of patients with resectable pancreatic adenosquamous cancer and found that the survival rate was low, with a 5-year survival rate of only 11.6%. Normal serum levels of Ca199 and Ca125 were identified as independent favorable prognostic factors for predicting prognosis.

FRONTIERS IN ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes

Ningzhen Fu, Weishen Wang, Dongfeng Cheng, Jiancheng Wang, Zhiwei Xu, Xiaxing Deng, Chenghong Peng, Hao Chen, Baiyong Shen

Summary: This study proposed a rescue staging system for pancreatic ductal adenocarcinoma patients with inadequate lymph node examination after pancreatoduodenectomy. The system showed better predictive capacity than the 8th AJCC staging system, as demonstrated by higher C-index values in both SEER and RJPDC databases.

PANCREATOLOGY (2021)

Article Cell Biology

A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications

Zengyu Feng, Kexian Li, Jianyao Lou, Mindi Ma, Yulian Wu, Hao Chen, Chenghong Peng

Summary: The study aims to develop a DNA replication-related gene signature to stratify PDAC patients treated with R0 resection based on recurrence risks. Pathway enrichment analysis suggests a close relationship with cell cycle, DNA replication, and DNA repair, potentially aiding in the identification of novel biomarkers and therapeutic targets for PDAC.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma

Zengyu Feng, Peng Chen, Kexian Li, Jianyao Lou, Yulian Wu, Tao Li, Chenghong Peng

Summary: This study developed an effective prognostic signature using ferroptosis-related genes to predict PDAC recurrence. The signature showed stability and independence in both training and validation cohorts, outperforming clinical indicators and previous models. Additionally, the signature was closely associated with multiple cancer-related and drug response pathways.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Editorial Material Oncology

ASO Visual Abstract: A Novel Criterion for Lymph Node Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database

Weishen Wang, Ziyun Shen, Jun Zhang, Hao Chen, Xiaxing Deng, Chenghong Peng, Junjie Xie, Zhiwei Xu, Baiyong Shen

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database

Weishen Wang, Ziyun Shen, Jun Zhang, Hao Chen, Xiaxing Deng, Chenghong Peng, Junjie Xie, Zhiwei Xu, Baiyong Shen

Summary: The study found that examining a minimum of 19 lymph nodes is crucial for ensuring quality lymph node detection and long-term survival in patients undergoing distal pancreatectomy for pancreatic ductal adenocarcinoma. The ideal cut-off value for lymph node examination was identified using Kaplan-Meier survival analysis and X-tile software.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway

Jiewei Lin, Shuyu Zhai, Siyi Zou, Zhiwei Xu, Jun Zhang, Lingxi Jiang, Xiaxing Deng, Hao Chen, Chenghong Peng, Jiaqiang Zhang, Baiyong Shen

Summary: The study found that FLVCR1-AS1 is downregulated in PC tissues and cell lines, and its overexpression suppresses proliferation, cell cycle, and migration of PC cells. Mechanistically, FLVCR1-AS1 acts as a ceRNA to sequester miR-513c-5p or miR-514b-5p from KLF10 mRNA, relieving their suppressive effects on KLF10 expression. Additionally, FLVCR1-AS1 was shown to be a direct transcriptional target of KLF10, suggesting a novel therapeutic strategy for PC treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Surgery

Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experience

Jiabin Jin, Shih-min Yin, Yuanchi Weng, Mengmin Chen, Yusheng Shi, Xiayang Ying, Georgios Gemenetzis, Kai Qin, Jun Zhang, Xiaxing Deng, Chenghong Peng, Baiyong Shen

Summary: This study compared the outcomes of venous resection and reconstruction (VR) in robotic-assisted and open pancreaticoduodenectomy (OPD) in patients with pancreatic ductal adenocarcinoma (PDAC). The results showed similar reconstructed venous patency, postoperative complications, and 90-day mortality between the two groups, but the robotic group had a lower lymph node resection rate.

LANGENBECKS ARCHIVES OF SURGERY (2022)

Article Medicine, Research & Experimental

Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial

Jiabin Jin, Yusheng Shi, Mengmin Chen, Jianfeng Qian, Kai Qin, Zhen Wang, Wei Chen, Weiwei Jin, Fengchun Lu, Zheyong Li, Zehua Wu, Li Jian, Bing Han, Xiao Liang, Chuandong Sun, Zheng Wu, Yiping Mou, Xiaoyu Yin, Heguang Huang, Hao Chen, Georgios Gemenetzis, Xiaxing Deng, Chenghong Peng, Baiyong Shen

Summary: The PORTAL trial is a multicenter randomized controlled trial comparing the outcomes of robotic pancreatoduodenectomy (RPD) and open pancreatoduodenectomy (OPD) in China. The trial will assess primary and secondary outcomes, as well as sub-cohort analysis of pancreatic adenocarcinoma (PDAC) patients.

TRIALS (2021)

Article Medicine, General & Internal

Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort

Qian Zhan, Chenlei Wen, Yi Zhao, Lu Fang, Yangbing Jin, Zehui Zhang, Siyi Zou, Fanlu Li, Ying Yang, Lijia Wu, Jiabin Jin, Xiongxiong Lu, Junjie Xie, Dongfeng Cheng, Zhiwei Xu, Jun Zhang, Jiancheng Wang, XiaXing Deng, Hao Chen, Chenghong Peng, Hongwei Li, Henghui Zhang, Hai Fang, Chaofu Wang, Baiyong Shen

Summary: The study revealed limited prognostic value of point mutations in highly mutated genes or homologous recombination repair genes in PAAD patients, while amplified genes involved in DNA repair and RTK related signalings were associated with worse prognosis. Molecular subtyping and prognostic model construction can stratify patients with low or high risk of relapse more effectively.

EBIOMEDICINE (2021)

Article Biochemistry & Molecular Biology

Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1

Shuyu Zhai, Zhiwei Xu, Junjie Xie, Jun Zhang, Xinjing Wang, Chenghong Peng, Hongwei Li, Hao Chen, Baiyong Shen, Xiaxing Deng

Summary: LINC00261 has been identified as a tumor suppressor in pancreatic cancer, inhibiting cancer progression through various mechanisms including inducing cell cycle arrest and apoptosis. Its expression levels are closely associated with pathological stage and prognosis, revealing its crucial role and regulatory mechanisms in pancreatic cancer.

ONCOGENE (2021)

暂无数据